Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rascol

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
British Journal of Pharmacology|April 1, 1989
Involvement of a pertussis toxin-sensitive G-protein in the pharmacological properties of septo-hippocampal neuronesO Rascol, P Dutar, Y Lamour
Therapie|October 1, 1988
[Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years]J L Montastruc, O Rascol, A Rascol
Clinical Neuropharmacology|October 1, 1992
Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depressionJ L Montastruc, O Rascol, P Montastruc
Fundamental & Clinical Pharmacology|January 1, 1989
Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drugO Rascol, M Clanet, J L Montastruc
Revue Neurologique|January 1, 1990
[Neuroleptic malignant-like syndrome following levodopa withdrawal]O Rascol, F Salachas, J L Montastruc
La Revue Du Praticien|May 15, 1997
[Parkinson "plus"]N Fabre, C Brefel-Courbon, O Rascol
La Revue Du Praticien|March 9, 1989
[Antiparkinsonian drugs]A Rascol, J L Montastruc, O Rascol
Clinical Neuropharmacology|October 1, 1987
Adrenal catecholamine concentration after domperidoneG Gaillard, O Rascol, J L Montastruc
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?A Rascol, J L Montastruc, O Rascol
Trends in Neurosciences|October 29, 2000
Continuous dopamine-receptor stimulation in early Parkinson's diseaseW Olanow, A H Schapira, O Rascol
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
British Journal of Pharmacology|April 1, 1989
Involvement of a pertussis toxin-sensitive G-protein in the pharmacological properties of septo-hippocampal neuronesO Rascol, P Dutar, Y Lamour
Therapie|October 1, 1988
[Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years]J L Montastruc, O Rascol, A Rascol
Clinical Neuropharmacology|October 1, 1992
Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depressionJ L Montastruc, O Rascol, P Montastruc
Fundamental & Clinical Pharmacology|January 1, 1989
Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drugO Rascol, M Clanet, J L Montastruc
Revue Neurologique|January 1, 1990
[Neuroleptic malignant-like syndrome following levodopa withdrawal]O Rascol, F Salachas, J L Montastruc
La Revue Du Praticien|May 15, 1997
[Parkinson "plus"]N Fabre, C Brefel-Courbon, O Rascol
La Revue Du Praticien|March 9, 1989
[Antiparkinsonian drugs]A Rascol, J L Montastruc, O Rascol
Clinical Neuropharmacology|October 1, 1987
Adrenal catecholamine concentration after domperidoneG Gaillard, O Rascol, J L Montastruc
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?A Rascol, J L Montastruc, O Rascol
Trends in Neurosciences|October 29, 2000
Continuous dopamine-receptor stimulation in early Parkinson's diseaseW Olanow, A H Schapira, O Rascol
Pageof 22